Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Douglas Dunn’s Limestone Value Partners’ Top Stock Picks

Douglas B. Dunn’s Limestone Value Partners LLC has filed its 13F with the SEC for the reporting period of June 30, 2015. The Houston, Texas-based hedge fund manager reported a public equity portfolio with $93.93 million of holdings, and was primarily invested in the finance and consumer discretionary sectors. During the second quarter, the investment manager sold out of positions in four stocks, including Delta Air Lines, Inc. (NYSE:DAL) and Buckeye Partners, L.P. (NYSE:BPL). Plains All American Pipeline, L.P. (NYSE:PAA) was its only new position initiated during the quarter. The top ten stock holdings of the fund account for 72.70% of its overall portfolio value. Realogy Holdings Corp (NYSE:RLGY), Comerica Incorporated (NYSE:CMA), and Time Warner Inc (NYSE:TWX) are the top three stock investments of the fund manager, and we’ll look at these picks in this article.

Biggest Film Studios in the World

Why are we interested in the 13F filings of a select group of hedge funds? We use these filings to determine the top 15 small-cap stocks held by these elite funds based on 16 years of research that showed their top small-cap picks are much more profitable than both their large-cap stocks and the broader market as a whole. These small-cap stocks beat the S&P 500 Total Return Index by an average of nearly one percentage point per month in our backtests, which were conducted over the period of 1999 to 2012. Moreover, since the beginning of forward testing from August 2012, the strategy worked just as our research predicted, outperforming the market every year and returning 139% over the last 34 months, which is more than 80 percentage points higher than the returns of the S&P 500 ETF (SPY) (see more details).

At the end of the second quarter, Limestone Value Partners had its largest equity investment in Realogy Holdings Corp (NYSE:RLGY), holding 223,400 shares valued at $10.44 million. The real estate brokerage firm will announce its second quarter 2015 financial results on July 31. Wall Street is expecting earnings per share of $0.70 over revenues of $1.65 billion for the quarter. According to a report published by the Wall Street Journal entitled The Thousand, nearly one-third of the top 1,500 real estate agents and teams have an affiliation with at least one of the real estate brands of Realogy Holdings Corp (NYSE:RLGY).

The shares of Realogy have received an average rating of ‘Hold’ from nine different analysts, with a 12-month price target of $52.25, representing an upside potential of 7.60% from its current share price. Lone Pine Capital, led by Stephen Mandel, and John Paulson’s Paulson & Co were among the primary investors of Realogy Holdings Corp (NYSE:RLGY) at the end of the first quarter. Stephen Mandel had 10.41 million shares in his portfolio valued at $473.29 million, whereas Paulson’s stake was worth $324.81 million and consisted of 7.14 million shares.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.